Accuray strikes deal with Siemens:
This article was originally published in Clinica
Radiosurgery systems developer Accuray is to combine its robotic radiosurgery technology with Siemens Medical Solutions' diagnostic imaging know-how, following a distribution and co-marketing deal between the two companies. Under the terms of the agreement, Accuray's CyberKnife robotic radiosurgery system and RoboCouch patient positioning system will be integrated into Siemen's Somatom computed tomography scanner with a sliding gantry configuration. Shares in Sunnyvale, California-based Accuray rose $0.42 (2%) to close at $23.78 on April 12, the day after the announcement.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.